KOD Jan 2025 0.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:30AM EDT. Market open.
| Previous close | 2.0300 |
| Open | 2.0300 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 0.50 |
| Expiry date | 2025-01-17 |
| Day's range | 2.0300 - 2.0300 |
| Contract range | N/A |
| Volume | |
| Open interest | 2 |
ZacksShould You Hold Kodiak Sciences (KOD) Stock in Your Portfolio?
Kodiak Sciences (KOD) is evaluating its lead candidate, tarcocimab, in a late-stage study for diabetic retinopathy, which is expected to support a regulatory filing for three eye disease indications.
ZacksWhy Is Kodiak Sciences (KOD) Down 26.2% Since Last Earnings Report?
Kodiak Sciences (KOD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
PR NewswireKodiak Sciences to Present at Upcoming Investor and Clinical Conferences
Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today that management will present at the following upcoming investor conferences:
© 2024 Yahoo. All rights reserved.